AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,988 | -64.8% | 16,086 | -56.2% | 0.00% | – |
| Q2 2023 | $355,556 | +61414.9% | 36,731 | -30.4% | 0.00% | – |
| Q1 2023 | $578 | +1.0% | 52,776 | -60.2% | 0.00% | – |
| Q4 2022 | $572 | -99.6% | 132,600 | +563.0% | 0.00% | – |
| Q3 2022 | $150,000 | -25.4% | 20,000 | 0.0% | 0.00% | – |
| Q2 2022 | $201,000 | -97.8% | 20,000 | -97.3% | 0.00% | -100.0% |
| Q1 2022 | $9,194,000 | +151.3% | 742,595 | +364.1% | 0.01% | +150.0% |
| Q4 2021 | $3,659,000 | -62.7% | 160,000 | -63.9% | 0.00% | -60.0% |
| Q3 2021 | $9,812,000 | +362.0% | 443,390 | +171.2% | 0.01% | +150.0% |
| Q1 2021 | $2,124,000 | +1017.9% | 163,508 | +1092.9% | 0.00% | – |
| Q4 2020 | $190,000 | -98.1% | 13,707 | -97.9% | 0.00% | -100.0% |
| Q3 2020 | $9,844,000 | +321.0% | 668,278 | +364.4% | 0.01% | +300.0% |
| Q2 2020 | $2,338,000 | -60.5% | 143,891 | -64.7% | 0.00% | -76.9% |
| Q1 2020 | $5,921,000 | -85.0% | 408,096 | -79.0% | 0.01% | -73.5% |
| Q4 2019 | $39,408,000 | +923.1% | 1,945,094 | +169.6% | 0.05% | +716.7% |
| Q3 2019 | $3,852,000 | +173.0% | 721,459 | +236.5% | 0.01% | +100.0% |
| Q2 2019 | $1,411,000 | -8.2% | 214,406 | -9.3% | 0.00% | 0.0% |
| Q1 2019 | $1,537,000 | +1297.3% | 236,424 | +872.8% | 0.00% | – |
| Q4 2017 | $110,000 | -55.8% | 24,303 | -38.8% | 0.00% | – |
| Q3 2017 | $249,000 | +22.7% | 39,700 | +19.9% | 0.00% | – |
| Q2 2017 | $203,000 | -71.1% | 33,099 | -65.4% | 0.00% | -100.0% |
| Q1 2017 | $703,000 | +375.0% | 95,758 | +35.5% | 0.00% | – |
| Q4 2016 | $148,000 | +6.5% | 70,693 | +41.4% | 0.00% | – |
| Q2 2016 | $139,000 | -67.1% | 50,000 | -65.6% | 0.00% | -100.0% |
| Q1 2016 | $423,000 | +17.8% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $359,000 | -12.9% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $412,000 | -6.2% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $439,000 | -30.1% | 145,200 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $628,000 | – | 144,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |